EcoDrugPlus

Toll Like Receptor 9

Ensembl ID : ENSCHYG00000015762
Gene Symbol: TLR9
1 Cross references
82 Possible Orthologues:

Transforming Growth Factor Beta Receptor 1

Ensembl ID : ENSCHYG00000026632
Gene Symbol: TGFBR1
1 Cross references
236 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1

Ensembl ID : ENSCHYG00000008486
Gene Symbol: TRPA1
1 Cross references
228 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily M Member 8

Ensembl ID : ENSCHYG00000010936
Gene Symbol: TRPM8
1 Cross references
158 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily V Member 1

Ensembl ID : ENSCHYG00000006931
Gene Symbol: TRPV1
1 Cross references
134 Possible Orthologues:

Translocator Protein

Ensembl ID : ENSCHYG00000025079
Gene Symbol: TSPO
1 Cross references
122 Possible Orthologues:

Transthyretin

Ensembl ID : ENSCHYG00000026307
Gene Symbol: TTR
1 Cross references
165 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSCHYG00000012793
Gene Symbol: TPH1
1 Cross references
257 Possible Orthologues:

Tubulin Alpha 1b

Ensembl ID : ENSCHYG00000003929
Gene Symbol: TUBA1B
1 Cross references
192 Possible Orthologues:

Tubulin Alpha 3c

Ensembl ID : ENSCHYG00000014951
Gene Symbol: TUBA3C
1 Cross references
152 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSCHYG00000000497
Gene Symbol: TUBA4A
1 Cross references
225 Possible Orthologues:

Tubulin Beta 1 Class Vi

Ensembl ID : ENSCHYG00000015260
Gene Symbol: TUBB1
1 Cross references
186 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).